Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Domestic, Prospective, Non-interventional Study of Remimazolam Tosilate for Injection in the Real-world for General Anesthesia and Fiberoptic Bronchoscopy Sedation

NCT05549791 is registered in ClinicalTrials.gov with Jiangsu HengRui Medicine Co., Ltd. as lead sponsor.

NCT NCT05549791
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05549791 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Domestic, Prospective, Non-interventional Study of Remimazolam Tosilate for Injection in the Real-world for General Anesthesia and Fiberoptic Bronchoscopy Sedation
Lead sponsor
Jiangsu HengRui Medicine Co., Ltd.
Phase
Observational
Overall status
Completed
Start date
August 18, 2022
Completion date
June 21, 2024
Enrollment
1,285 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

general anesthesia and bronchoscopy sedation